Cargando…
Obesity and poor breast cancer prognosis: an illusion because of hormone replacement therapy?
High body mass index (BMI) and use of hormone replacement therapy (HRT) increase the risk of postmenopausal breast cancer. It has been shown that BMI modifies the effect of HRT, as its influence is most pronounced in lean women. We investigated the influence of BMI and HRT on prognosis in 2640 postm...
Autores principales: | Rosenberg, L, Czene, K, Hall, P |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2009
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2694417/ https://www.ncbi.nlm.nih.gov/pubmed/19367278 http://dx.doi.org/10.1038/sj.bjc.6605025 |
Ejemplares similares
-
Family history of breast cancer and young age at diagnosis of breast cancer increase risk of second primary malignancies in women: a population-based cohort study
por: Prochazka, M, et al.
Publicado: (2006) -
Hormone replacement therapy and risks of oesophageal and gastric adenocarcinomas
por: Lindblad, M, et al.
Publicado: (2006) -
Background risk of breast cancer influences the association between alcohol consumption and mammographic density
por: Trinh, T, et al.
Publicado: (2015) -
An overview of menopausal oestrogen–progestin hormone therapy and breast cancer risk
por: Lee, S A, et al.
Publicado: (2005) -
Breast cancer prognosis in relation to family history of breast and ovarian cancer
por: Thalib, L, et al.
Publicado: (2004)